Task: Answer Verification
Input (English): Question: Does age worsen the efficacy nor tolerance to combined induction therapies in locally advanced non-small cell lung cancer?
Answer: Age by itself did not significantly worsen either the efficacy or tolerance to combined induction and definitive treatment in patients with LA-NSCLC and Eastern Cooperative Oncology Group performance status 0-2.
Output (English): no